Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$23.49 - $30.56 $915,851 - $1.19 Million
-38,989 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$16.78 - $27.3 $503 - $819
-30 Reduced 0.08%
38,989 $1.02 Million
Q3 2020

Nov 13, 2020

BUY
$12.46 - $19.98 $3,700 - $5,934
297 Added 0.77%
39,019 $679,000
Q2 2020

Aug 14, 2020

BUY
$11.0 - $18.26 $31,878 - $52,917
2,898 Added 8.09%
38,722 $651,000
Q4 2019

Feb 19, 2020

BUY
$12.06 - $16.96 $13,036 - $18,333
1,081 Added 3.11%
35,824 $433,000
Q3 2019

Nov 05, 2019

SELL
$10.41 - $14.66 $1,519 - $2,140
-146 Reduced 0.42%
34,743 $491,000
Q2 2019

Aug 12, 2019

BUY
$9.78 - $12.76 $13,310 - $17,366
1,361 Added 4.06%
34,889 $389,000
Q1 2019

May 07, 2019

BUY
$10.03 - $15.71 $8,976 - $14,060
895 Added 2.74%
33,528 $394,000
Q4 2018

Feb 13, 2019

BUY
$11.29 - $17.19 $15,139 - $23,051
1,341 Added 4.29%
32,633 $436,000
Q3 2018

Nov 13, 2018

BUY
$12.27 - $15.65 $45,055 - $57,466
3,672 Added 13.29%
31,292 $439,000
Q2 2018

Aug 14, 2018

BUY
$15.3 - $19.69 $18,054 - $23,234
1,180 Added 4.46%
27,620 $434,000
Q1 2018

May 14, 2018

BUY
$14.59 - $25.5 $68,003 - $118,855
4,661 Added 21.4%
26,440 $435,000
Q4 2017

Feb 14, 2018

BUY
$15.77 - $20.72 $343,454 - $451,260
21,779
21,779 $393,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.62B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Mason Street Advisors, LLC Portfolio

Follow Mason Street Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mason Street Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mason Street Advisors, LLC with notifications on news.